Concepedia

Linda Kessler

LK

Statistics

Publications

25

Citations

2.7K

H-Index

17

Active since

1994

Affiliations

Kura Oncology (United States)(Current)

Ligand Pharmaceuticals (United States)

Wellspring Biosciences (United States)

Hospital Universitario 12 De Octubre

MD Anderson Cancer Center Madrid

Linda Kessler is an author at Kura Oncology (United States) specializing in molecular oncology, pharmacology, and oncology.

Publications per year

1994–2024

25

Publications

25

Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor

Matthew R. Janes, Jingchuan Zhang, Lian‐Sheng Li et al. · Cell · 2018 · 1.2K citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +12

Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State

Matthew P. Patricelli, Matthew R. Janes, Lian‐Sheng Li et al. · Cancer Discovery · 2016 · 754 citations · Full text

Medicine, Medicinal Chemistry, Oncology +17

A Small, Nonpeptidyl Mimic of Granulocyte-Colony- Stimulating Factor

Shin-Shay Tian, Peter Lamb, Andrew King et al. · Science · 1998 · 154 citations

Life Sciences, Immunology, Molecular Biology +16

Hydrogel wound dressings: where do we stand in 2003?

David E. Eisenbud, Heather Hunter, Linda Kessler et al. · PubMed · 2003 · 92 citations

Nursing, Biomedical Engineering, Surgery +17

Selective Inhibition of Phosphoinositide 3-Kinase p110α Preserves Lymphocyte Function*

Lomon So, Sung Su Yea, Jean Oak et al. · Journal of Biological Chemistry · 2012 · 63 citations · Full text

Life Sciences, Cell Biology, Immunology +10

1–5 of 25